Adverse Reactions & Antiretroviral Therapy Kirsten B. Balano, PharmD October 26, 2002.

Slides:



Advertisements
Similar presentations
TB & HIV Infection: Treatment
Advertisements

TB & HIV Infection: Treatment Your name Institution/organization Meeting Date International Standard 8, 13 TB & HIV Infection: Treatment Your name Institution/organization.
Key1 ARV Treatment Guidelines for a Public Health Approach Product Selection for HIV Treatment Vincent Habiyambere January 2006.
ART in HIV-Infected Patients with TB: Research Priorities Group II Facilitator: David Cohn Rapporteur: Soumya Swaminathan.
ARV failure and resistance for the paediatrician
Slide #1 HIV Entry Inhibitors Trip Gulick, MD, MPH Director, Cornell HIV Clinical Trials Unit Associate Professor of Medicine Weill Medical College of.
Antiretroviral Combinations James A Zachary MD LSU Health Sciences Center HIV Outpatient Clinic December 13, 2004
ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis Adherence.
Therapeutic Options New Options & New Challenges James A Zachary MD LSU Health Sciences Center HIV Outpatient Clinic 11 April 2005.
Pre Test !!!!!!. How many classes of HIV meds are currently available?
Principles of care of the HIV-1 infected pregnant mother Protection of mothers from mono- and dual- therapies likely to induce resistance: Women refusing.
Antiretroviral drugs in UMMC Presenter: TE CHIN YEW Preceptor: KHOO SU LIN.
Antiretroviral Therapy: Pharmacology Cristina Gruta, PharmD, Asst. Clinical Professor of Clinical Pharmacy and FCM San Francisco AIDS Education and Training.
Practical Aspects of Antiretroviral Therapy
Prescription and Use of Paediatric Antiretroviral Drugs (ARVs) for the Treatment of HIV in Children.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
KITSO AIDS Training Program
Principles of HIV Therapy Simple is Better! Adeel A. Butt, MD Assistant Professor of Medicine and Infectious Diseases University of Pittsburgh Director,
HIV Care 2010: The 3 rd Revolution in HIV treatment Chris Farnitano, MD Noon Conference February 11, 2010.
S.Collins: HIV i-Base TAC training - March 2006 Medical timeline Observation or research ideaY0 Pilot study -design, ethics approval, screen enroll1-2.
Salvage Antiretroviral Therapy Guiding Principles, Strategies and the Role of Resistance Testing.
Presented by: Siti Rohaizah bt Othman. Arv DRUGS AVAILABLE IN UMMC Combivir (Lamivudine + Zidovudine) Stocrin (Efavirenz 600mg) Kaletra (Lopinavir 200mg.
Charge to the Committee Kimberly Struble, Pharm.D. Regulatory Review Officer Division of Antiviral Drug Products.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
1 Side Effects of Anti-retroviral Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Introduction to new drugs: I-Base training London - May 2007 Introduction to new drugs African Treatment Advocacy Training 31 May 2007 Simon Collins
HIV/ AIDS Answers to your questions. What is HIV HIV- Human Immunodeficiency Virus HIV- Human Immunodeficiency Virus The virus attacks the T-Cells in.
Introduction to ARV therapy
Symptom Control of Cancer Treatment
Improving Adherence With Simplified HAART Regimens Improving Clinical Outcomes in HIV Patients.
Ardis Ann Moe, M.D. UCLA CARE clinic/NEVHC Van Nuys HIV Clinic 28 August 2015.
Nurses SOAR! Training Curricula Series For More Information and Inquiries:
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
Rubin_MDS218_final1 Managing Adverse Effects of HAART David Rubin, MD Clinical Assistant Professor of Medicine Weill Cornell Medical College Medical Director,
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Indications for Initiation of ARV Therapy in Children Age >1 Year Clinical Category CD4 + Cell Percentage Plasma HIV RNA Copy Number Recommendation AIDS.
Measuring Adherence to Chronic Disease Treatment Using Dispensing Data: An Example from Thailand Sauwakon Ratanawijitrasin, PhD Sanita Hirunrassamee, PhD.
WHO - PSM 14/7/2005 Principles for selection of medicines Dr Mary R. Couper Quality Assurance and Safety of Medicines WHO.
Guidelines for the use of antiretroviral agents in HIV infections in Taiwan, revised in 2002 by Infectious Diseases Society of the ROC and Taiwan AIDS.
Virsuses: Human Immunodeficiency Syndrome & Acquired Immunodeficiency Syndrome.
TO EVALUATE EARLY ANTIVIRAL RESPONSE AND SAFETY OF A DUAL BOOSTED PROTEASE INHIBITORS REGIMEN INCLUDING LOPINAVIR/r (LPV) PLUS AMPRENAVIR (AMP) OR FORTOVASE.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Clinical Case #25 Yvonne Josephine Banarez Pharmacology -A- October 12, 2006.
Highlights of the 43rd Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC) September 14-17, 2003; Chicago, Illinois Selected and summarized.
Current Concepts in HIV/AIDS A Pharmacy Perspective Carol Schneiderman, Pharm D Clinical Pharmacist, University of Arizona.
1 Second Line ART: Doses & Side Effects HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Key1 ARV Treatment Guidelines for a Public Health Approach Product Selection for HIV Treatment Vincent Habiyambere February 2006.
Current and Future Trends in HIV Therapy Hail M. Al-Abdely Consultant, Infectious Diseases.
Prophylaxis of Opportunistic Infections
Highly Active Antiretroviral Therapy (HAART) Cocktail Therapy
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
Second Line ARV: Doses & Side Effects HAIVN Harvard Medical School AIDS Initiative in Vietnam.
11 INTRODUCTION TO ANTIRETROVIRAL THERAPY (ART) IN CHILDREN: INITIATION AND MONITORING HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Side effects of antiretroviral drugs
Retrovirus HIV (humans) Animal viruses resulting in cancer / AIDS 15-39%
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
ART 101 Successful HIV treatment usually consists of at least three drugs from two different “classes” of ARV drugs There are now six classes of ARV drugs:
Learning Objectives By the end of the session, participants will:
Answers to your questions
LPV-RTV versus LPV-RTV + ZDV-3TC in Treatment-Naïve MONARK Trial
Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses 
EVALUATION OF ANTIRETROVIRAL THERAPY FOLLOWED BY AN EDUCATIONAL INTERVENTION TO INCREASE APPROPRIATE USE IN ZIMBABWE.
St Stephen’s Centre, Chelsea & Westminster Hospital, United Kingdom
School of Pharmacy, University of Nizwa
Forecasting for ARVs medicines
Antiretroviral therapy and its complications
Presentation transcript:

Adverse Reactions & Antiretroviral Therapy Kirsten B. Balano, PharmD October 26, 2002

Challenges associated with antiretroviral therapy:  When to start medications?  When to change medications?  What medications to start with?  What medications to change to when fail?

The most effective regimen for HIV infected individuals is the one they will take.

How to achieve 100% adherence?  Prior to therapy educate client on therapeutic goals  Review regimen, how to take, how to store  Review and manage side-effects as they occur

Common Adverse Effects Nausea/Vomiting Diarrhea Rash Fatigue

Case Report: 38 yo man with AIDS, history of several antiretroviral regimens in the past, including AZT, 3TC, IDV and was non-adherent with these regimens, primarily due to intolerance. Current CD4 150, VL 400,000 Has been working closely with his NP and case manager over the past 1.5 years to consider restarting ARV. Three days ago was begun on salvage regimen: Abacavir, Combivir, Amprenavir, Ritonavir, Efavirenz, continues Septra. Comes in for adherence check with new regimen, complaining of intolerable dizziness and nausea

Nausea Antiretroviral agents most commonly associated with nausea: –Zidovudine (AZT, ZDV, Retrovir) –Didanosine (ddI, Videx) –Abacavir (ABC, Ziagen) –All of the protease inhibitors –Tenofovir – gas/bloating & flatulence

Abacavir Hypersensitivity Occurs in 3-5% of pts Most commonly by day 10 of start Associated with fever, nausea, GI symptoms, respiratory symptoms and possibly a rash Increasing intensity of symptoms with subsequent doses DO NOT RECHALLENGE

Nausea: Other possible causes Drug Related –Acute hepatitis –Acute pancreatitis Gastrointestinal Disease CNS Disease

Nausea Counseling Reassure pt symptoms decrease over first month Don’t stop meds without advice from physician Double check dosage and administration –IDV can be given with lite snacks if alone and with food if with RTV –ddI with very cold water can decrease nausea Consider holding supplements/vitamins or other less vital medications

Nausea Management Avoid greasy, fried foods Eat small, frequent snacks or meals Ginger - Ginger Tea, Ginger Ale, Ginger Snaps Mint and/or simethicone for gas/bloating Consider antiemetics (i.e. prochorperazine 10mg BID – TID, marinol, marijuana) If anticipatory nausea is part of the origin, consider adjust regimen to decrease number of pills (if clinically appropriate) or lorazepam 0.5mg 30 min before meds

Strategies to Limit Pill Burden Ritonavir Boosted Regimens –IDV RTV 100/200 twice daily –APV RTV 100/200 twice daily –Lopinavir/ritonavir – Kaletra Once Daily Regimens – may increase pill burden –SQV 1200/1600 +RTV 100/200 –APV RTV 200

Case Report: Three days ago was begun on salvage regimen: Abacavir, Combivir, Amprenavir, Ritonavir, Efavirenz, continues Septra. Comes in for adherence check with new regimen, complaining of intolerable dizziness and nausea Pill Burden: –Abacavir 1 BID, Combivir 1 BID, Amprenavir 8 BID, Ritonavir 2 BID, Efavirenz 3 Qhs, Septra 1 QD –13 pills AM, 15 pill PM Switch Indinavir 2 BID, Ritonavir 2 BID, Trizivir 1 BID, Nevirapine 1 BID –7 pills AM, 6 pills PM

Common Adverse Effects Nausea/Vomiting Diarrhea Rash Fatigue

Diarrhea: Antiretrovirals most likely to cause diarrhea –ddI (tablet/powder formulation) –Abacavir –Nelfinavir –Ritonavir –Amprenavir –Lopinavir

Diarrhea Management Nelfinavir: Access to lomotil or loperamide before starting nelfinavir. Usually will lessen within 1 month of continued treatment Dose escalation of ritonavir, even if using 400mg BID, can decrease adverse effects in first 2 weeks of treatment ddI: related to buffer in tablet. Make sure number of tablets appropriately minimal or switch formulations - Videx EC. Abacavir – concern related to hypersensitivity reaction – need to monitor carefully

Diarrhea Management cont. Psyllium (metamucil) Calcium Carbonate Iron Pancrelipase (i.e. Ultrase) 1-2 capsules with meals and snacks.

Common Adverse Effects Nausea/Vomiting Diarrhea Rash Fatigue

Rash: Antiretrovirals commonly associated with rash: –Nevirapine –Delavirdine –Amprenavir Rash also seen with (but less likely) –Abacavir, 3TC, Nelfinavir, Efavirenz

Rash Management Rule out SJS rash - painful & involve conjunctiva & mucosa) Most are self-limiting with continued treatment and will resolve w/in 2-3 weeks. Supportive care including creams for dryness and antipruitics for itching (i.e. diphenhydramine or doxepin) Use of sunscreen can decrease likelihood of rash/phonosensitivity Nevirapine – dose escalation decreases likelihood rash (200mg QD x 2wk then 200 mg BID) Abacavir – r/o hypersensitivity reaction, with other symptoms present.

Common Adverse Effects Nausea/Vomiting Diarrhea Rash Fatigue

Case Report: Switch Indinavir 2 BID, Ritonavir 2 BID, Trizivir 1 BID, Nevirapine 1 BID, Continue Septra Several weeks later, partner calls complaining of being so tired taking so many meds Is it possible to stop one medicine?

Fatigue Antiretrovirals most associated with fatigue: –Zidovudine –Efavirenz Pill Fatigue –Protease Inhibitors

Strategies to Limit Pill Burden Ritonavir Boosted Regimens –IDV RTV 100/200 twice daily –APV RTV 100/200 twice daily –Lopinavir/ritonavir – Kaletra Once Daily Regimens –SQV 1200/1600 +RTV 100/200 –APV RTV 200

Fatigue Management Symptoms should resolve after 4-6 weeks of a new regimen Zidovudine: need to rule out anemia, especially if associated with SOB, palpitations, loss of color Efavirenz: Consider splitting dose or taking early in evening rather than bedtime. CNS symptoms usually resolve by 2-4 weeks continued treatment.

Case Report: Switch Indinavir 2 BID, Ritonavir 2 BID, Trizivir 1 BID, Nevirapine 1 BID, Continue Septra Several weeks later, partner calls complaining of being so tired taking so many meds Is it possible to stop one medicine? So tired, short of breath walking up stairs and across parking lot. Hct Transfusion Switch Trizivir to D4T(Zerit), 3TC (Epivir), Abacavir (Ziagen)

Questions?